Navigation Links
BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
Date:9/4/2007

The most powerful inflammation fighter of any known botanical now widely

available

EGG HARBOR TOWNSHIP., N.J., Sept. 4 /PRNewswire/ -- BSP Pharma Inc., based in Egg Harbor Township, NJ, has announced the distribution of its new, all natural dietary supplement FlexNow(TM) Joint Formula in Vitamin Shoppe stores (http://www.vitaminshoppe.com) nationally as well as at select GNC stores (http://www.gnc.com) throughout the country.

"With the national launch of FlexNow Joint Formula earlier this year, we are continuing to see success and demand for our product," stated Leonard P. Smith, CEO and President of BSP Pharma Inc. "Distribution in Vitamin Shoppe and select GNC outlets introduces FlexNow to a larger market and to those suffering from chronic joint discomfort," he added.

FlexNow(TM) Joint Formula is an all natural dietary supplement made with one ingredient: shea nut triterpenes, the most powerful inflammation fighter of any known botanical. Harvested in the wild in West Africa, the shea nut (the nut is actually the pit of the shea fruit) which produces shea oil has been used for centuries as a food product and more recently as an effective additive to cosmetics and moisturizers (shea butter). Research revealed that the shea nut contains the most unique complex of Nature's Inflammation Fighters(TM), triterpenes, of any known botanical.

Since inflammation is a primary contributor to joint problems, BSP Pharma conducted pharmacological and clinical research into the anti-inflammatory properties of triterpene esters found in the shea nut triterpenes. Positive results led the way to the development of FlexNow Joint Formula. Reports on the clinical studies are available at: http://www.FlexNow.us Extensive research on shea nut triterpene extract also proved safety, including lack of gastric lesions.

FlexNow Joint Formula was one of only seven dietary supplement products accepted by the FDA in 2004 to meet all the safety requirements under the Dietary Supplement Health and Education Act. FlexNow offers a full guarantee, complete relief in 30 days or complete refund.

About BSP Pharma

BSP Pharma Inc., a subsidiary of BSP Pharma A/S of Denmark, is based in Egg Harbor Township, NJ, and was formed in 2005 to bring the remarkable shea nut health products to market. BSP's CEO and President Leonard P. Smith has held senior level positions in the nutraceutical and pharmaceutical industry for more than 20 years. At Lactaid Inc. he led the company's flagship product, Lactaid(R), through explosive growth. While running Lactaid(R), Smith developed Beano(R), a successful legend in the nutraceutical field. For product availability and additional information visit the company's website http://www.FlexNow.us.

Lactaid(R) is a registered trademark of Johnson & Johnson.

Beano(R) is a registered trademark of GlaxoSmithKline.


'/>"/>
SOURCE BSP Pharma Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):